Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.21T | 998.56B | 763.62B | 541.14B | 368.06B | Gross Profit |
584.76B | 593.17B | 541.80B | 398.63B | 257.36B | EBIT |
166.87B | 115.69B | 171.12B | 145.54B | 64.88B | EBITDA |
222.30B | 171.81B | 203.33B | 169.83B | 80.78B | Net Income Common Stockholders |
87.24B | 35.45B | 366.85B | 81.10B | 37.49B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.58T | 3.20T | 2.50T | 802.70B | 843.75B | Total Assets |
27.14T | 22.31T | 17.84T | 7.21T | 5.51T | Total Debt |
4.48T | 4.29T | 3.96T | 2.00T | 1.50T | Net Debt |
-103.26B | 1.08T | 1.46T | 1.19T | 657.00B | Total Liabilities |
25.23T | 20.56T | 16.25T | 6.49T | 4.92T | Stockholders Equity |
1.26T | 1.01T | 924.60B | 562.12B | 451.48B |
Cash Flow | Free Cash Flow | |||
1.30T | 923.17B | -340.01B | -193.82B | 12.60B | Operating Cash Flow |
1.35T | 960.74B | -314.05B | -178.40B | 26.85B | Investing Cash Flow |
-65.12B | -1.08T | 1.84T | -82.07B | -70.89B | Financing Cash Flow |
123.86B | 810.42B | 163.30B | 210.82B | 181.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $1.11T | 8.50 | 12.69% | 4.10% | 16.64% | 36.46% | |
72 Outperform | $2.33T | 7.12 | 9.88% | 6.29% | 13.94% | 109.60% | |
71 Outperform | $3.10T | 8.27 | 10.07% | 4.42% | 8.18% | 43.83% | |
66 Neutral | $1.27T | 8.58 | 9.63% | 5.72% | 7.08% | 28.63% | |
64 Neutral | $12.60B | 9.73 | 7.92% | 16985.68% | 12.21% | -5.55% | |
62 Neutral | $8.62T | 9.76 | 8.56% | 3.30% | 22.26% | 36.36% | |
61 Neutral | $19.66T | 10.45 | 9.70% | 3.43% | 21.88% | -3.60% |
SBI Holdings has announced the partial sale of its shares in SBI Savings Bank to Kyobo Life Insurance, a strategic move aimed at recovering investment and deepening cooperation with Kyobo Life. This transaction will eventually result in SBI Savings Bank transitioning from a consolidated subsidiary to an equity-method affiliate, with Kyobo Life gaining a majority of voting rights, while SBI Holdings retains significant economic interest.
SBI Holdings has decided to acquire additional shares of Kyobo Life Insurance Co., Ltd., a leading life insurance company in Korea, to make it an equity-method affiliate. This acquisition aims to strengthen their cooperation and expand SBI’s insurance business, although the financial impact on SBI’s results for the fiscal year ending March 2026 is expected to be negligible.
SBI Holdings announced that its subsidiary, SBI Shinsei Bank, has partially repaid public funds by paying a special dividend of 100 billion and 2 Yen to the government, funded from its capital surplus. This move is part of an agreement with the Deposit Insurance Corporation of Japan and the Resolution and Collection Corporation, aiming to enhance the bank’s customer base, profitability, and corporate value while working towards full repayment of public funds.
SBI Holdings has announced the sale of its operational investment securities to a subsidiary, resulting in a gain of JPY 99.8 billion in its non-consolidated financial results for the fiscal year ending March 31, 2025. This transaction will not affect the company’s consolidated financial results, as the gain will be eliminated in the consolidated financial statements.
SBI Holdings has completed the acquisition of Solaris SE, making it a consolidated subsidiary. The acquisition, finalized after regulatory approvals, significantly increases SBI’s shareholding in Solaris SE to 88.88%. This move is expected to have a minor impact on SBI’s consolidated financial results for the fiscal year ending March 31, 2025.